Approved Policies, Procedures and Guidelines
-
MU IBC Charter (Revised - 8/12/2013)
-
MU IBC Policy Statement on Toxins of Biological Origin (Revised - 8/13/2013)
-
MU IBC Policy Statment on Human/Nonhuman Primate Cell Lines (Revised - 3/22/2012)
-
MU IBC Policy Statement on Transgenic Animals (Revised - 10/31/2013)
-
MU IBC Core Facility Guidelines (Revised - 8/13/2013)
-
MU IBC Policy Statement on Transgenic Plants (Revised - 5/16/2014)
-
MU IBC Guidelines for Adenovirus Use in Research (Adopted - 3/22/2012)
-
MU IBC Guidelines for Lentivirus Use in Research (Adopted - 4/26/2012)
-
MU IBC Human Gene Transfer Trials Serious Adverse Event Reporting Policy (Adopted - 11/21/2013)
-
MU IBC Policy on IBC Meeting Minutes (Adopted - 1/23/2014)
-
MU IBC Policy on Redacting IBC Meeting Minutes (Adopted - 2/27/2014)
-
MU IBC Policy on Receipt and Transmission of Public Comments (Adopted - 1/23/2014)
-
MU IBC Conflict of Interest Policy (Adopted - 1/23/2014)
-
MU IBC Dual Use Research of Concern (DURC) (Adopted - 9/17/2015)
-
MU IBC Policy on Renewals, Suspensions, and Terminations of Protocols (Adopted - 10/25/2018)
-
MU Vaccination Policy and Surveillance Guidelines (login required) (approved by IBC 3/17/2022)